Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Kratom In Supplements Reaches Dead End On DEA Direct Regulatory Path

WarningSign_1200x675

Related Content

Health & Wellness Industry News Roundup: Week Of Aug. 1

Aug 05 2016

Kratom Action Presents Regulatory Puzzle For FDA

Oct 04 2013

Durbin Letter To USPlabs Targets Latest Supplement Adulterant

Oct 30 2013

Ephedra Back On Regulatory Radar As Supplement Adulterant

Jan 02 2012

Kratom Import Alert Clarifies FDA Deems The Botanical An Unsafe NDI

Mar 21 2014

Additional Topics

United States Dietary Supplements Regulation Consumer

More from United States

More from North America

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window